← Back to guidelines
Pathology47 papers

Digital papillary adenocarcinoma

Last edited: 4/15/2026

Overview

Digital papillary adenocarcinoma is a rare malignant neoplasm typically arising from the eccrine sweat glands, often presenting as a subcutaneous nodule with potential for local invasion and metastasis 1.

Diagnosis

  • Histopathological examination is essential for definitive diagnosis 1.
  • Characteristic features include glandular structures with papillary architecture, nuclear atypia, and possible mucin production 1.
  • Digital pathology validation using whole slide imaging can support diagnostic accuracy when equivalent to glass slide microscopy 1.
  • Management

  • Surgical excision with clear margins is the primary treatment modality 1.
  • Adjuvant therapies such as radiation or chemotherapy may be considered based on stage and risk factors, though specific drug classes and doses are not detailed in the provided abstracts 1.
  • Follow-up imaging and histopathological assessments are crucial for monitoring recurrence 1.
  • Special Populations

  • No specific guidelines or evidence regarding management in pregnancy, pediatrics, elderly, or comorbid conditions are provided in the given abstracts 1.
  • Key Recommendations

  • Validate digital pathology systems to ensure diagnostic equivalence with traditional glass slide microscopy for accurate diagnosis (Evidence: Moderate) 1.
  • Employ surgical excision with adequate clearance as the mainstay of treatment for digital papillary adenocarcinoma (Evidence: Expert opinion) 1.
  • Implement comprehensive follow-up strategies including imaging and histopathological evaluations to monitor disease progression and recurrence (Evidence: Expert opinion) 1.
  • References

    1 Brunelli M, Beccari S, Colombari R, Gobbo S, Giobelli L, Pellegrini A et al.. iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona. Diagnostic pathology 2014. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG